BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 9714433)

  • 1. Incidence and significance of 22q11.2 hemizygosity in patients with interrupted aortic arch.
    Rauch A; Hofbeck M; Leipold G; Klinge J; Trautmann U; Kirsch M; Singer H; Pfeiffer RA
    Am J Med Genet; 1998 Jul; 78(4):322-31. PubMed ID: 9714433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosome 22q11.2 microdeletions in velocardiofacial syndrome patients with widely variable manifestations.
    Ravnan JB; Chen E; Golabi M; Lebo RV
    Am J Med Genet; 1996 Dec; 66(3):250-6. PubMed ID: 8985481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microsatellite DNA markers detects 95% of chromosome 22q11 deletions.
    Bonnet D; Cormier-Daire V; Kachaner J; Szezepanski I; Souillard P; Sidi D; Munnich A; Lyonnet S
    Am J Med Genet; 1997 Jan; 68(2):182-4. PubMed ID: 9028455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetralogy of Fallot with pulmonary atresia associated with chromosome 22q11 deletion.
    Momma K; Kondo C; Matsuoka R
    J Am Coll Cardiol; 1996 Jan; 27(1):198-202. PubMed ID: 8522695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of 22q11.2 deletion among 139 patients with Di George/Velocardiofacial syndrome features.
    Kitsiou-Tzeli S; Kolialexi A; Fryssira H; Galla-Voumvouraki A; Salavoura K; Kanariou M; Tsangaris GT; Kanavakis E; Mavrou A
    In Vivo; 2004; 18(5):603-8. PubMed ID: 15523900
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A genetic etiology for interruption of the aortic arch type B.
    Lewin MB; Lindsay EA; Jurecic V; Goytia V; Towbin JA; Baldini A
    Am J Cardiol; 1997 Aug; 80(4):493-7. PubMed ID: 9285664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Submicroscopic deletions at 22q11.2: variability of the clinical picture and delineation of a commonly deleted region.
    Lindsay EA; Greenberg F; Shaffer LG; Shapira SK; Scambler PJ; Baldini A
    Am J Med Genet; 1995 Mar; 56(2):191-7. PubMed ID: 7625444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-probe fluorescence in situ hybridization assay for detecting deletions associated with VCFS/DiGeorge syndrome I and DiGeorge syndrome II loci.
    Berend SA; Spikes AS; Kashork CD; Wu JM; Daw SC; Scambler PJ; Shaffer LG
    Am J Med Genet; 2000 Apr; 91(4):313-7. PubMed ID: 10766989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interrupted aortic arch: an epidemiologic study.
    Loffredo CA; Ferencz C; Wilson PD; Lurie IW
    Teratology; 2000 May; 61(5):368-75. PubMed ID: 10777832
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Congenital heart defects and chromosomal anomalies including 22q11 microdeletion (CATCH 22).
    Soares G; Alvares S; Rocha C; Teixeira MF; Mota MC; Reis MI; Feijó MJ; Lima MR; Pinto MR
    Rev Port Cardiol; 2005 Mar; 24(3):349-71. PubMed ID: 15929620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical heterogeneity of the chromosome 22q11 microdeletion syndrome].
    Muñoz S; Garay F; Flores I; Heusser F; Talesnik E; Aracena M; Mellado C; Méndez C; Arnaiz P; Repetto G
    Rev Med Chil; 2001 May; 129(5):515-21. PubMed ID: 11464533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Congenital cardiovascular malformations and chromosome microdeletions in 22q11.2].
    Trost D; Engels H; Bauriedel G; Wiebe W; Schwanitz G
    Dtsch Med Wochenschr; 1999 Jan; 124(1-2):3-7. PubMed ID: 9951451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chromosome 22q11 deletions in patients with selected outflow tract malformations.
    Frohn-Mulder IM; Wesby Swaay E; Bouwhuis C; Van Hemel JO; Gerritsma E; Niermeyer MF; Hess J
    Genet Couns; 1999; 10(1):35-41. PubMed ID: 10191427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of 22q11 in two brothers with different phenotype.
    Kasprzak L; Der Kaloustian VM; Elliott AM; Shevell M; Lejtenyi C; Eydoux P
    Am J Med Genet; 1998 Jan; 75(3):288-91. PubMed ID: 9475599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A common region of 10p deleted in DiGeorge and velocardiofacial syndromes.
    Daw SC; Taylor C; Kraman M; Call K; Mao J; Schuffenhauer S; Meitinger T; Lipson T; Goodship J; Scambler P
    Nat Genet; 1996 Aug; 13(4):458-60. PubMed ID: 8696341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of microdeletions of chromosomal region 22q11 as a cause of selected malformations of the ventricular outflow tracts and aortic arch: a three-year prospective study.
    Webber SA; Hatchwell E; Barber JC; Daubeney PE; Crolla JA; Salmon AP; Keeton BR; Temple IK; Dennis NR
    J Pediatr; 1996 Jul; 129(1):26-32. PubMed ID: 8757559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac defects and results of cardiac surgery in 22q11.2 deletion syndrome.
    Carotti A; Digilio MC; Piacentini G; Saffirio C; Di Donato RM; Marino B
    Dev Disabil Res Rev; 2008; 14(1):35-42. PubMed ID: 18636635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular cytogenetic analysis of a series of 23 DiGeorge syndrome patients by fluorescence in situ hybridization.
    Demczuk S; Desmaze C; Aikem M; Prieur M; Ledeist F; Sanson M; Rouleau G; Thomas G; Aurias A
    Ann Genet; 1994; 37(2):60-5. PubMed ID: 7985979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microdeletion of 22q11 (CATCH 22) in children with conotruncal heart defect and extracardiac malformations.
    Alikaşifoğlu M; Malkoç N; Ceviz N; Ozme S; Uludoğan S; Tunçbilek E
    Turk J Pediatr; 2000; 42(3):215-8. PubMed ID: 11105620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Velo-cardio-facial syndrome and DiGeorge sequence with meningomyelocele and deletions of the 22q11 region.
    Nickel RE; Pillers DA; Merkens M; Magenis RE; Driscoll DA; Emanuel BS; Zonana J
    Am J Med Genet; 1994 Oct; 52(4):445-9. PubMed ID: 7747757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.